跳至主要内容
临床试验/DRKS00015648
DRKS00015648已完成4 期

Prospective Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of Vliwaktiv® Ag

ohmann & Rauscher GmbH & Co. KG0 个研究点目标入组 58 人开始时间: 2018年10月9日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age = 18 years
  • Patient is legally capable
  • Presence of a wound according to the instruction for use:
  • - venous leg ulcer or
  • - arterial ulcer (ABPI < 0,5) or
  • - arterial and venous leg ulcer (ABPI > 0,5) or
  • - pressure ulcer (category II – IV) or
  • - diabetic foot ulcer or
  • - post-operative wound healing disturbance or
  • - exulcerating tumors
  • Infected wound or wound with risk of infection (W.A.R. Score = 3)
  • Estimated survival time > 8 weeks
  • Wound area between 4 und 20 cm2
  • Patient has signed written Informed Consent

排除标准

  • Treatment with Vliwaktiv® Ag Activated Charcoal Dressing and Rope with Silver or a similar dressing during the last 4 weeks prior to study start
  • Known sensitivity to Vliwaktiv® Ag Activated Charcoal Dressing and Rope with Silver or any of their components
  • Critical limb ischemia
  • Planned amputation in the next 2 months
  • A planned surgical operation in the region of the study wound in the next 8 weeks following inclusion
  • Patient is not compliant regarding treatment of the underlying disease (e.g. compression)
  • Dry wound
  • Pregnancy or breast feeding
  • Reliable severe malnutrition
  • Patient is analphabet
  • Participation in a therapeutic trial in the last 3 months and during participation in this study

研究者

发起方
ohmann & Rauscher GmbH & Co. KG

相似试验